|
|
|
| | |
| | | | | | |
organism-gene
|
|
PR:000050263 rep gene translation product (SARS-CoV-2) | ORF1ab (SARS2) |
|
|
|
|
|
|
| | | | |
| | | | |
organism-modification
|
|
PR:000050281 rep gene proteolytic cleavage product (SARS-CoV-2) | rep/ClvPrd (SARS2) |
|
|
|
|
|
|
|
|
|
|
| | | | | | |
| | |
organism-modification
|
|
PR:000050274 3C-like proteinase nsp5 (SARS-CoV-2) | rep/Clv:nsp5 (SARS2) |
|
|
|
|
|
|
|
|
|
|
|
| | | | | | |
| | |
organism-modification
|
|
PR:000050282 ORF1a proteolytic cleavage product (SARS-CoV-2) | ORF1a/ClvPrd (SARS2) |
|
|
|
|
|
|
| | | | | | | | |
|
organism-modification
|
|
PR:000050280 non-structural protein 11 (SARS-CoV-2) | rep/Clv:nsp11 (SARS2) |
|
|
|
|
|
|
| | | | | | |
| | |
organism-modification
|
|
PR:000050283 ORF1ab proteolytic cleavage product (SARS-CoV-2) | ORF1ab/ClvPrd (SARS2) |
|
|
|
|
|
|
|
|
| | | | | | | | |
|
|
|
PR:000050286 proofreading exoribonuclease nsp14 (SARS-CoV-2) | |
|
|
|
|
|
|
| | | | | | | | |
|
|
|
PR:000050287 uridylate-specific endoribonuclease nsp15 (SARS-CoV-2) | |
|
|
|
|
|
|
|
| | | | | | |
| | |
organism-modification
|
|
PR:000050289 NSP2-3 intermediate (SARS-CoV-2) | rep/Clv:nsp2-3 (SARS2) |
|
|
|
|
|
|
|
| | | | | | |
| | |
organism-modification
|
|
PR:000050282 ORF1a proteolytic cleavage product (SARS-CoV-2) | ORF1a/ClvPrd (SARS2) |
|
|
|
|
|
|
| | | | | | | | |
|
organism-modification
|
|
PR:000050280 non-structural protein 11 (SARS-CoV-2) | rep/Clv:nsp11 (SARS2) |
|
|
|
|
|
|
|
| | | | | | |
| | |
organism-modification
|
|
PR:000050283 ORF1ab proteolytic cleavage product (SARS-CoV-2) | ORF1ab/ClvPrd (SARS2) |
|
|
|
|
|
|
|
|
| | | | | | | | |
|
|
|
PR:000050286 proofreading exoribonuclease nsp14 (SARS-CoV-2) | |
|
|
|
|
|
|
| | | | | | | | |
|
|
|
PR:000050287 uridylate-specific endoribonuclease nsp15 (SARS-CoV-2) | |
|
|
|
|
|